Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens

Li Ping Tseng, Chwei Jang Chiou, Chien Chung Chen, Ming Chung Deng, Tze Wen Chung, Yi You Huang, Der Zen Liu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In order to potentiate the low immunogenicity of the inactivated Newcastle disease virus immunized into chickens by mucosal route, liposomes as a drug delivery system and LPS (lipopolysaccharide) as an immuno-stimulator were evaluated. Here, we report a new nasal delivery system of inactivated Newcastle disease virus (NDV) vaccine. The intranasal vaccine was based on different lipids to form MLV (multi-lamellar vehicles) liposomes. The liposomes had combined carrier and adjuvant activities, which induced strong systemic (serum) and local (lung and nasal) humoral responses in SPF (specific-pathogen-free) chickens, and provided protective immunity. PC-Lip (phosphatidylcholine-liposome) elicited significant mucosal secretary immunoglobulin A (s-IgA) levels (p <0.05) in tracheal lavage fluid and serum IgG levels (p <0.05). In response to virulent viral challenge, birds treated with PBS (phosphate buffered saline) as control group died, whereas 80% of chickens which received PC-Lip, PC-Lip-LPS, PS-Lip (phosphatidylserine-liposome), and PS-Lip-LPS survived. HAI titers were 1:2560 in the PS-Lip-LPS group and 1:1280 in the PC-Lip, PC-Lip-LPS, and PS-Lip groups after two vaccinations. The results suggest that PC-Lip or PS-Lip might thus be suitable as a potential adjuvant for mucosal vaccination against NDV in chickens.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
JournalVeterinary Immunology and Immunopathology
Volume131
Issue number3-4
DOIs
Publication statusPublished - Oct 15 2009

Fingerprint

intranasal administration
Specific Pathogen-Free Organisms
Intranasal Administration
Newcastle disease virus
phosphatidylserines
Liposomes
phosphatidylcholines
lipopolysaccharides
Lipopolysaccharides
Chickens
Vaccines
vaccines
chickens
pathogens
Phosphatidylcholines
Phosphatidylserines
adjuvants
vaccination
drug delivery systems
immunoglobulin A

Keywords

  • Adjuvant
  • Intranasal
  • Liposome
  • LPS
  • Newcastle disease virus
  • s-IgA

ASJC Scopus subject areas

  • Immunology
  • veterinary(all)

Cite this

Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens. / Tseng, Li Ping; Chiou, Chwei Jang; Chen, Chien Chung; Deng, Ming Chung; Chung, Tze Wen; Huang, Yi You; Liu, Der Zen.

In: Veterinary Immunology and Immunopathology, Vol. 131, No. 3-4, 15.10.2009, p. 285-289.

Research output: Contribution to journalArticle

Tseng, Li Ping ; Chiou, Chwei Jang ; Chen, Chien Chung ; Deng, Ming Chung ; Chung, Tze Wen ; Huang, Yi You ; Liu, Der Zen. / Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens. In: Veterinary Immunology and Immunopathology. 2009 ; Vol. 131, No. 3-4. pp. 285-289.
@article{a4dcbafd54234d93904edb5e1e577608,
title = "Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens",
abstract = "In order to potentiate the low immunogenicity of the inactivated Newcastle disease virus immunized into chickens by mucosal route, liposomes as a drug delivery system and LPS (lipopolysaccharide) as an immuno-stimulator were evaluated. Here, we report a new nasal delivery system of inactivated Newcastle disease virus (NDV) vaccine. The intranasal vaccine was based on different lipids to form MLV (multi-lamellar vehicles) liposomes. The liposomes had combined carrier and adjuvant activities, which induced strong systemic (serum) and local (lung and nasal) humoral responses in SPF (specific-pathogen-free) chickens, and provided protective immunity. PC-Lip (phosphatidylcholine-liposome) elicited significant mucosal secretary immunoglobulin A (s-IgA) levels (p <0.05) in tracheal lavage fluid and serum IgG levels (p <0.05). In response to virulent viral challenge, birds treated with PBS (phosphate buffered saline) as control group died, whereas 80{\%} of chickens which received PC-Lip, PC-Lip-LPS, PS-Lip (phosphatidylserine-liposome), and PS-Lip-LPS survived. HAI titers were 1:2560 in the PS-Lip-LPS group and 1:1280 in the PC-Lip, PC-Lip-LPS, and PS-Lip groups after two vaccinations. The results suggest that PC-Lip or PS-Lip might thus be suitable as a potential adjuvant for mucosal vaccination against NDV in chickens.",
keywords = "Adjuvant, Intranasal, Liposome, LPS, Newcastle disease virus, s-IgA",
author = "Tseng, {Li Ping} and Chiou, {Chwei Jang} and Chen, {Chien Chung} and Deng, {Ming Chung} and Chung, {Tze Wen} and Huang, {Yi You} and Liu, {Der Zen}",
year = "2009",
month = "10",
day = "15",
doi = "10.1016/j.vetimm.2009.04.009",
language = "English",
volume = "131",
pages = "285--289",
journal = "Veterinary Immunology and Immunopathology",
issn = "0165-2427",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens

AU - Tseng, Li Ping

AU - Chiou, Chwei Jang

AU - Chen, Chien Chung

AU - Deng, Ming Chung

AU - Chung, Tze Wen

AU - Huang, Yi You

AU - Liu, Der Zen

PY - 2009/10/15

Y1 - 2009/10/15

N2 - In order to potentiate the low immunogenicity of the inactivated Newcastle disease virus immunized into chickens by mucosal route, liposomes as a drug delivery system and LPS (lipopolysaccharide) as an immuno-stimulator were evaluated. Here, we report a new nasal delivery system of inactivated Newcastle disease virus (NDV) vaccine. The intranasal vaccine was based on different lipids to form MLV (multi-lamellar vehicles) liposomes. The liposomes had combined carrier and adjuvant activities, which induced strong systemic (serum) and local (lung and nasal) humoral responses in SPF (specific-pathogen-free) chickens, and provided protective immunity. PC-Lip (phosphatidylcholine-liposome) elicited significant mucosal secretary immunoglobulin A (s-IgA) levels (p <0.05) in tracheal lavage fluid and serum IgG levels (p <0.05). In response to virulent viral challenge, birds treated with PBS (phosphate buffered saline) as control group died, whereas 80% of chickens which received PC-Lip, PC-Lip-LPS, PS-Lip (phosphatidylserine-liposome), and PS-Lip-LPS survived. HAI titers were 1:2560 in the PS-Lip-LPS group and 1:1280 in the PC-Lip, PC-Lip-LPS, and PS-Lip groups after two vaccinations. The results suggest that PC-Lip or PS-Lip might thus be suitable as a potential adjuvant for mucosal vaccination against NDV in chickens.

AB - In order to potentiate the low immunogenicity of the inactivated Newcastle disease virus immunized into chickens by mucosal route, liposomes as a drug delivery system and LPS (lipopolysaccharide) as an immuno-stimulator were evaluated. Here, we report a new nasal delivery system of inactivated Newcastle disease virus (NDV) vaccine. The intranasal vaccine was based on different lipids to form MLV (multi-lamellar vehicles) liposomes. The liposomes had combined carrier and adjuvant activities, which induced strong systemic (serum) and local (lung and nasal) humoral responses in SPF (specific-pathogen-free) chickens, and provided protective immunity. PC-Lip (phosphatidylcholine-liposome) elicited significant mucosal secretary immunoglobulin A (s-IgA) levels (p <0.05) in tracheal lavage fluid and serum IgG levels (p <0.05). In response to virulent viral challenge, birds treated with PBS (phosphate buffered saline) as control group died, whereas 80% of chickens which received PC-Lip, PC-Lip-LPS, PS-Lip (phosphatidylserine-liposome), and PS-Lip-LPS survived. HAI titers were 1:2560 in the PS-Lip-LPS group and 1:1280 in the PC-Lip, PC-Lip-LPS, and PS-Lip groups after two vaccinations. The results suggest that PC-Lip or PS-Lip might thus be suitable as a potential adjuvant for mucosal vaccination against NDV in chickens.

KW - Adjuvant

KW - Intranasal

KW - Liposome

KW - LPS

KW - Newcastle disease virus

KW - s-IgA

UR - http://www.scopus.com/inward/record.url?scp=70249126148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249126148&partnerID=8YFLogxK

U2 - 10.1016/j.vetimm.2009.04.009

DO - 10.1016/j.vetimm.2009.04.009

M3 - Article

C2 - 19439366

AN - SCOPUS:70249126148

VL - 131

SP - 285

EP - 289

JO - Veterinary Immunology and Immunopathology

JF - Veterinary Immunology and Immunopathology

SN - 0165-2427

IS - 3-4

ER -